Skip to main content
. 2017 Nov 2;25(9):1567–1578. doi: 10.3727/096504017X14897173032733

Figure 5.

Figure 5

Capecitabine-based versus capecitabine-free combination adjuvant chemotherapy: meta-analysis of breast cancer-specific survival.